Drug Shortage Report for SANDOZ OMEPRAZOLE

Last updated on 2021-12-06 History
Report ID 145904
Drug Identification Number 02296438
Brand name SANDOZ OMEPRAZOLE
Common or Proper name OMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OMEPRAZOLE
Strength(s) 10MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 30GRC BO
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-09-20
Estimated end date 2021-12-03
Actual end date 2021-12-06
Shortage status Resolved
Updated date 2021-12-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-12-06 French Compare
v10 2021-12-06 English Compare
v9 2021-11-29 French Compare
v8 2021-11-29 English Compare
v7 2021-11-24 French Compare
v6 2021-11-24 English Compare
v5 2021-10-19 French Compare
v4 2021-10-19 English Compare
v3 2021-09-21 English Compare
v2 2021-09-20 French Compare
v1 2021-09-20 English Compare

Showing 1 to 11 of 11